Powles, Thomas http://orcid.org/0000-0001-7760-4724
Kockx, Mark
Rodriguez-Vida, Alejo
Duran, Ignacio
Crabb, Simon J. http://orcid.org/0000-0003-3521-9064
Van Der Heijden, Michiel S.
Szabados, Bernadett
Pous, Albert Font
Gravis, Gwenaelle
Herranz, Urbano Anido http://orcid.org/0000-0003-0376-5642
Protheroe, Andrew http://orcid.org/0000-0001-9413-0575
Ravaud, Alain
Maillet, Denis
Mendez, Maria Jose http://orcid.org/0000-0002-7460-1859
Suarez, Cristina
Linch, Mark
Prendergast, Aaron http://orcid.org/0000-0002-9668-6689
van Dam, Pieter-Jan http://orcid.org/0000-0001-9074-8271
Stanoeva, Diana
Daelemans, Sofie
Mariathasan, Sanjeev
Tea, Joy S. http://orcid.org/0000-0002-3395-149X
Mousa, Kelly
Banchereau, Romain
Castellano, Daniel
Funding for this research was provided by:
Roche (MO29593)
The CECM received additional core funding by the UK Experimental Cancer Medicine Network. Mr Jonathan Bull and Mr Michael Jacobson also provided financial support for aspects of the biomarker analysis
Article History
First Online: 15 May 2020
Free to read: This content has been made available to all.